These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 14578100)
1. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Lowder JN; Whelton P Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100 [TBL] [Abstract][Full Text] [Related]
10. Microbial contamination of harvested bone marrow and peripheral blood. Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761 [TBL] [Abstract][Full Text] [Related]
12. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975 [TBL] [Abstract][Full Text] [Related]
13. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts. Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612 [TBL] [Abstract][Full Text] [Related]
14. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? Kelly M; Roy DC; Labbe AC; Laverdiere M Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868 [TBL] [Abstract][Full Text] [Related]
15. Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution. Mele L; Dallavalle FM; Verri MG; Balza G; Allione B; Salvi F; Levis A; Caraccio V; Borzini P Transfus Apher Sci; 2005 Nov; 33(3):269-74. PubMed ID: 16239124 [TBL] [Abstract][Full Text] [Related]
16. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984 [TBL] [Abstract][Full Text] [Related]
17. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience. Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409 [TBL] [Abstract][Full Text] [Related]
18. Ex-vivo purging of hematopoietic progenitor cells. de Lima M; Shpall EJ Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555 [TBL] [Abstract][Full Text] [Related]
19. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209 [TBL] [Abstract][Full Text] [Related]
20. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method. Khuu HM; Patel N; Carter CS; Murray PR; Read EJ Transfusion; 2006 Dec; 46(12):2071-82. PubMed ID: 17176318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]